Richard A Moscicki's Net Worth

$16.5 Million

Estimate Recalculated Sep 8, 2024 07:30PM EST

Who is Richard A Moscicki?

Richard A Moscicki has an estimated net worth of $16.5 Million. This is based on reported shares across multiple companies, which include GENZYME CORP, LogicBio Therapeutics, Inc., and AKCEA THERAPEUTICS, INC..

SEC CIK

Richard A Moscicki's CIK is 0001021029

Past Insider Trading and Trends

2008 was Richard A Moscicki's most active year for acquiring shares with 7 total transactions. Richard A Moscicki's most active month to acquire stocks was the month of April. 2004 was Richard A Moscicki's most active year for disposing of shares, totalling 21 transactions. Richard A Moscicki's most active month to dispose stocks was the month of June. 2008 saw Richard A Moscicki paying a total of $4,813,864.68 for 197,189 shares, this is the most they've acquired in one year. In 2008 Richard A Moscicki cashed out on 329,712 shares for a total of $12,775,603.55, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

GENZYME CORP No price found

Sr VP,Chief Medical Officer

Richard A Moscicki owns 8,350 units of Genzyme General common stock (GENZ). Richard A Moscicki used to own units in Genzyme common stock (GENZ) but no longer holds any shares there.acquired a total of 360,934 shares in GENZYME CORP at a cost of $7,574,811.42, Richard also disposed a total of 354,103 shares of GENZYME CORP equalling to $24,093,653.72.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-21.05K
$74.00
-$2,723,940.00
0
Apr 4
Form 4
—
0
—
—
0
Jun 16
Form 4
+34.58%
5.35K
$45.63
-$124,615.53
20.83K
May 24 - May 25
Form 4
—
0
$38.60
-$443,295.60
15.48K
May 14
Form 4
—
0
—
—
0
May 21
Form 4
—
0
$52.55
-$1,771,965.11
15.48K
Scheduled
Sep 23
Form 4
—
0
$50.72
-$1,559,185.60
15.48K
Scheduled
Jun 25
Form 4
—
0
—
—
0
May 22
Form 4
—
0
$55.72
-$2,406,880.08
15.48K
Scheduled
Jan 17
Form 4
—
0
$53.72
-$2,223,708.08
15.48K
Scheduled
Jan 8
Form 4
-57.95%
-21.33K
$74.68
-$1,593,223.12
15.48K
Scheduled
Dec 31
Form 4
—
0
—
—
0
May 24
Form 4
+35.30%
9.61K
$60.32
$579,373.60
36.81K
Mar 12
Form 4
—
0
—
—
0
May 25
Form 4/A
+400.60%
21.34K
$15.13
$322,934.72
26.67K
Jan 4
Form 4
+400.98%
21.34K
$15.13
$322,934.72
26.67K
Jan 4
Form 4
-46.71%
-4.67K
$73.01
-$340,664.66
5.32K
Dec 16
Form 4/A
-31.84%
-4.67K
$72.01
-$335,998.66
9.99K
Dec 13
Form 4
-31.84%
-4.67K
$72.01
-$335,998.66
9.99K
Dec 6
Form 4
—
0
—
—
0
May 26
Form 4
+63.42%
5.51K
$32.72
-$1,216,550.24
14.19K
Jul 23
Form 4
-1.87%
-159.00
—
—
8.35K
Feb 2 - May 27
Form 4
—
0
$29.64
-$2,684,192.00
6.9K
Scheduled
Jul 28
Form 4
—
0
—
—
0
Scheduled
Form 4
—
0
—
—
0
Scheduled
Form 4
—
0
—
—
0
Form 4
—
0
—
—
0
No matching records found

LogicBio Therapeutics, Inc. No price found

Investor

Richard A Moscicki used to own units in Common Stock but no longer holds any shares there. In the year 2018 Richard A Moscicki filed a total of 8 filings.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-3.92K
—
—
0
Nov 16
Form 4
—
0
—
—
0
Jun 17
Form 4
—
0
—
—
0
Jun 11
Form 4
∞
3.92K
—
—
3.92K
Jan 1
Form 4
—
0
—
—
0
Jun 19
Form 4
—
0
—
—
0
Dec 19
Form 4
—
0
—
—
0
Oct 18
Form 3
—
0
—
—
0
No matching records found

AKCEA THERAPEUTICS, INC. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 14
Form 4
—
0
—
—
0
Jun 1
Form 3
—
0
—
—
0
No matching records found